/https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/81b09027d1bb06ad1c3c061937a5c81b.jpg)
Creepy Nigth Stories
Creator at Obomedia
The Insulin Vial and the Unseen Killer
OCT 21, 202621 MIN
/https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/81b09027d1bb06ad1c3c061937a5c81b.jpg)
Description
The Insulin Vial and the Unseen Killer
A private investigator found an insulin vial in his home, despite no one in the house having diabetes. Days later, he was found dead in his garage with no obvious cause of death, his body positioned as if someone had tried to move him. What did he uncover that led to his mysterious end?
In this episode, we delve into the strange death of Jim Capello, a private investigator who began surveilling his own wife after finding unprescribed opioids and an insulin vial in their home. We explore the unsettling details of his final days and the chilling statement he made to his best friend.
Person: Jim Capello
Date: September 22, 2018
Location: Huntsville, Alabama
Status: Unexplained death
Object: Insulin vial
- Jim Capello was found dead in his garage on September 22, 2018, lying face-up on a tarp with his feet against a car.
- He was 37 years old at the time of his death and had no history of diabetes.
- Jim found unprescribed opioids and an insulin vial in his home in 2018.
- He told his best friend, Matt Hombokel, "if you ever find me dead, it was my wife."
- Jim began showing symptoms consistent with dangerously low blood sugar in mid-September 2018.
To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.
© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: [email protected].

